198 related articles for article (PubMed ID: 28425581)
1. Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention.
Li SS; He JW; Fu WZ; Liu YJ; Hu YQ; Zhang ZL
J Bone Miner Res; 2017 Aug; 32(8):1659-1666. PubMed ID: 28425581
[TBL] [Abstract][Full Text] [Related]
2. Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy.
Xu Y; Zhang Z; Yue H; Li S; Zhang Z
J Bone Miner Res; 2021 Aug; 36(8):1459-1468. PubMed ID: 33852188
[TBL] [Abstract][Full Text] [Related]
3. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study.
Hou Y; Lin Y; Qi X; Yuan L; Liao R; Pang Q; Cui L; Jiang Y; Wang O; Li M; Dong J; Xia W
Bone; 2018 Jan; 106():96-102. PubMed ID: 28963081
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: A single-arm intervention trial.
Yuan L; Liao RX; Lin YY; Jiang Y; Wang O; Li M; Xing XP; Pang QQ; Hsieh E; Xia WB
J Orthop Translat; 2019 Jul; 18():109-118. PubMed ID: 31508314
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations.
Lu Q; Xu Y; Li S; Zhang Z; Sheng J; Zhang Z
Int J Biol Sci; 2022; 18(9):3908-3917. PubMed ID: 35813463
[TBL] [Abstract][Full Text] [Related]
6. Novel SLCO2A1compound heterozygous mutation causing primary hypertrophic osteoarthropathy with Bartter-like hypokalemia in a Chinese family.
Jiang Y; Du J; Song YW; Wang WB; Pang QQ; Li M; Wang O; Lian XL; Xing XP; Xia WB
J Endocrinol Invest; 2019 Oct; 42(10):1245-1252. PubMed ID: 31004291
[TBL] [Abstract][Full Text] [Related]
7. Two novel mutations in the SLCO2A1 gene in a Chinese patient with primary hypertrophic osteoarthropathy.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
Gene; 2014 Jan; 534(2):421-3. PubMed ID: 24185079
[TBL] [Abstract][Full Text] [Related]
8. Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy.
Cheng R; Li M; Guo Y; Yao Y; Gao C; Yao Z
Eur J Dermatol; 2013; 23(5):636-9. PubMed ID: 24153155
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bone microstructure and strength in the distal radius and tibia between the different types of primary hypertrophic osteoarthropathy: an HR-pQCT study.
Pang Q; Xu Y; Liao R; Li Y; Zhang L; Chi Y; Qi X; Li M; Jiang Y; Wang O; Xing X; Qin L; Xia W
Osteoporos Int; 2023 Aug; 34(8):1453-1464. PubMed ID: 37202541
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
J Clin Endocrinol Metab; 2013 May; 98(5):E923-33. PubMed ID: 23509104
[TBL] [Abstract][Full Text] [Related]
11. Primary hypertrophic osteoarthropathy: genetics, clinical features and management.
Lu Q; Xu Y; Zhang Z; Li S; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1235040. PubMed ID: 37705574
[TBL] [Abstract][Full Text] [Related]
12. The first case of primary hypertrophic osteoarthropathy with soft tissue giant tumors caused by HPGD loss-of-function mutation.
Pang Q; Xu Y; Qi X; Jiang Y; Wang O; Li M; Xing X; Qin L; Xia W
Endocr Connect; 2019 Jun; 8(6):736-744. PubMed ID: 31063976
[TBL] [Abstract][Full Text] [Related]
13. Novel pathogenic variants in SLCO2A1 causing autosomal dominant primary hypertrophic osteoarthropathy.
Bloch A; Couture G; Isidor B; Ricquebourg M; Bourrat E; Lipsker D; Taillan B; Combier A; Chiaverini C; Moufle F; Delobel B; Richette P; Collet C
Eur J Med Genet; 2023 Feb; 66(2):104689. PubMed ID: 36549465
[TBL] [Abstract][Full Text] [Related]
14. A Common Mutation and a Novel Mutation in the HPGD Gene in Nine Patients with Primary Hypertrophic Osteoarthropathy.
Yuan L; Chen L; Liao RX; Lin YY; Jiang Y; Wang O; Li M; Xing XP; Pang QQ; Jiajue R; Xia WB
Calcif Tissue Int; 2015 Oct; 97(4):336-42. PubMed ID: 26135126
[TBL] [Abstract][Full Text] [Related]
15. Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature.
Wang Q; Li YH; Lin GL; Li Y; Zhou WX; Qian JM; Xia WB; Wu D
Orphanet J Rare Dis; 2019 Dec; 14(1):297. PubMed ID: 31878983
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in the SLCO2A1 gene in a Chinese family with primary hypertrophic osteoarthropathy.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
Gene; 2013 May; 521(1):191-4. PubMed ID: 23531451
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.
Lee S; Park SY; Kwon HJ; Lee CH; Kim OH; Rhee Y
J Korean Med Sci; 2016 May; 31(5):735-42. PubMed ID: 27134495
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of pachydermoperiostosis patients with etoricoxib, aescin, and arthroscopic synovectomy: Two case reports.
Zhang H; Yang B
Medicine (Baltimore); 2017 Nov; 96(47):e8865. PubMed ID: 29382005
[TBL] [Abstract][Full Text] [Related]
19. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis.
Sasaki T; Niizeki H; Shimizu A; Shiohama A; Hirakiyama A; Okuyama T; Seki A; Kabashima K; Otsuka A; Ishiko A; Tanese K; Miyakawa S; Sakabe J; Kuwahara M; Amagai M; Okano H; Suematsu M; Kudoh J
J Dermatol Sci; 2012 Oct; 68(1):36-44. PubMed ID: 22906430
[TBL] [Abstract][Full Text] [Related]
20. [Genetic diagnosis for a Chinese Han family with primary hypertrophic osteoarthropathy].
Wang L; Yu J; Li Y; Liu X; Zhang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):213-7. PubMed ID: 25863089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
